Lemsip Max All In One Liquid

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Cetylpyridinium chloride; Guaifenesin; Paracetamol; Phenylephrine hydrochloride

Available from:

Reckitt Benckiser Healthcare (UK) Ltd

ATC code:

N02BE51

INN (International Name):

Cetylpyridinium chloride; Guaifenesin; Paracetamol; Phenylephrine hydrochloride

Dosage:

150microgram/1ml ; 10mg/1ml ; 50mg/1ml ; 609microgram/1ml

Pharmaceutical form:

Oral solution

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Never Valid To Prescribe As A VMP

Product summary:

BNF: 04070100; GTIN: 5000158066915

Patient Information leaflet

CUSTOMER INFO
Minimum Point Size =12.00pt
3240645
2D Code
Barcode Type:
Code Value:
Magnification:
BARCODE INFO
Overall Height:
BWR Applied:
6.11 mm
0 Micrometre
N/A %
Bar Height:
N/A mm
RB Artwork and
Print Specification
Trident Reference No:
ZEN Ref:
Action:
Brand:
Category:
Segment Group:
Segment:
Pack Size:
Market/Country:
Date:
RB520251
TR2492831
A
Lemsip
Max
All in One
Syrup
160 ml
UK
07/05/2022
RBH Contact:
Rachel Beresfordward
Artwork Type: BW Commercial
3240645
Edgemark Position:
N/A
Component Code
(if applicable):
N/A
2
nd
3rd Party Code:
Pharmacode No/NE:
Component Code
(2D if applicable):
Supply Point:
Finished Goods Code:
Parent Technical Packaging Specification:
N/A
N/A
RB Hull
3001403
D0125810
CAD Cam Ref:
Printer:
Substrate:
G-Lflt-D0125810-148x210mm
Westrock MPS (Tewkesbury, UK)
Paper White
Technical & Non Printing Items
Black
1
LTH
Colours
Dieline
Guides
Dieline 2 (if applicable)
Guides 2 (if applicable)
UNDER NO CIRCUMSTANCES SHOULD THIS
ARTWORK BE ALTERED WITHOUT PRIOR
PERMISSION FROM TRIDENT.
Please note that any low resolution paper Canon colour copies
associated with this job should be referred to for content, layout
and colour separation only.
STUDIO USE ONLY
Veerapahu Sudalaimuthu
v2.0
Connaught House, Connaught Road,
Kingswood Business Park, Hull, HU7 3AP, England.
T:[phone]
PACKAGE LEAFLET: INFORMATION FOR THE USER
LEMSIP MAX ALL IN ONE LIQUID
(paracetamol, guaifenesin, phenylephrine hydrochloride and
cetylpyridinium chloride)
READ THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION
FOR YOU.
• Keep this leaflet. You may need to read it again.
• Ask your pharmacist if you need more information or advice.
• You must contact a doctor or pharmacist if your symptoms worsen or
do not improve.
IN THIS LEAFLET:
1. What this medicine is and what it is used for
2. What you need to know before you take this medicine
3. How to take this medicine
4. Possible side effects
5. How to store this medicine
6. Contents of the pack and other information
1. WHAT THIS MEDICINE

Summary of Product characteristics

OBJECT 1
LEMSIP MAX ALL IN ONE LIQUID
Summary of Product Characteristics Updated 30-Jun-2022 | Reckitt
Benckiser Healthcare (UK) Ltd
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Lemsip Max All In One Liquid
2. Qualitative and quantitative composition
Active Ingredients
mg/20ml
Paracetamol
1000
Guaifenesin
200
Phenylephrine hydrochloride
12.18
Cetylpyridinium Chloride
3.0
Excipient(s) with known effect:
- Ethanol
3000 mg/20ml
- Maltitol liquid
2000 mg/20ml
- Propylene glycol
4300 mg/20ml
- Sodium
19 mg/20ml
- Sorbitol
3000 mg/20ml
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Oral Solution
4. Clinical particulars
4.1 Therapeutic indications
For the short term symptomatic relief of the symptoms of colds and
influenza, including aches and pains,
headache, nasal congestion, tickly sore throat and chesty coughs.
4.2 Posology and method of administration
For short term use only. Duration of treatment should be limited to a
maximum of 3 days. Patie